Contraindicated. Coadministration of doravirine with a robust CYP3A inducer may reduce doravirine plasma concentrations and/or effects. Prospective for loss of virologic response and achievable resistance to doravirine.pentobarbital will lessen the level or result of meloxicam by impacting hepatic enzyme CYP2C9/10 metabolism. Insignificant/Importan… Read More